Allay Therapeutics announced a $57.5 million Series D financing co-led by Lightstone Ventures and ClavystBio, with participation from existing investors NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare and Brandon Capital.
Moximed announced that the first patients had been treated in a randomized controlled trial evaluating the MISHA Knee System against non-surgical treatments for knee osteoarthritis.
Bicycle Therapeutics and the UK Nuclear Decommissioning Authority reached an agreement enabling the work. Bicycle was co-founded by Sir Greg Winter, who received the 2018 Nobel Prize in Chemistry.
Vertex Ventures HC is a healthcare and life sciences VC fund with a portfolio spanning medical devices, biotech, diagnostics and digital health services.
Vertex Ventures HC is a healthcare and life sciences VC fund with a portfolio spanning medical devices, biotech, diagnostics and digital health services.
